Used primarily in pharmaceutical research as an intermediate in the synthesis of bioactive molecules. Its structure supports the development of compounds with potential neurological and psychiatric applications due to the presence of the methylpiperazine moiety, commonly found in drugs affecting central nervous system receptors. Also explored in the design of enzyme inhibitors and receptor ligands, particularly for serotonin and dopamine receptor subtypes. Additionally, serves as a building block in medicinal chemistry for optimizing drug candidates with improved solubility and binding affinity.